Lindbrook Capital’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$917 Sell
34
-153
-82% -$4.84K ﹤0.01% 2487
2024
Q4
$6.71K Buy
187
+100
+115% +$3.74K ﹤0.01% 1847
2024
Q3
$3.3K Sell
87
-104
-54% -$4.27K ﹤0.01% 2177
2024
Q2
$8.64K Sell
191
-57
-23% -$2.62K ﹤0.01% 1708
2024
Q1
$12K Sell
248
-74
-23% -$3.62K ﹤0.01% 1467
2023
Q4
$17.3K Buy
322
+185
+135% +$9.36K ﹤0.01% 1259
2023
Q3
$8.03K Sell
137
-8
-6% -$500 ﹤0.01% 1524
2023
Q2
$9.14K Sell
145
-21
-13% -$1.34K ﹤0.01% 1516
2023
Q1
$10.4K Buy
166
+9
+6% +$537 ﹤0.01% 1430
2022
Q4
$8.35K Buy
157
+35
+29% +$1.9K ﹤0.01% 1524
2022
Q3
$7K Buy
122
+14
+13% +$925 ﹤0.01% 1519
2022
Q2
$8K Sell
108
-3
-3% -$223 ﹤0.01% 1369
2022
Q1
$9K Buy
111
+8
+8% +$721 ﹤0.01% 1350
2021
Q4
$10K Hold
103
﹤0.01% 1285
2021
Q3
$9K Hold
103
﹤0.01% 1056
2021
Q2
$11K Hold
103
﹤0.01% 1031
2021
Q1
$10K Hold
103
﹤0.01% 1035
2020
Q4
$8K Hold
103
﹤0.01% 1015
2020
Q3
$8K Hold
103
﹤0.01% 931
2020
Q2
$8K Hold
103
﹤0.01% 926
2020
Q1
$6K Buy
+103
New +$7.16K ﹤0.01% 948

Other funds holding USNA

Lindbrook Capital's USNA Position: Q1 2025 in Review

Lindbrook Capital reduced its Usana Health Sciences (USNA) stake by 82% in Q1 2025, selling an estimated $4.84K and leaving 34 shares worth $917. The position accounts for ﹤0.01% of the portfolio, ranked #2487.

Lindbrook Capital first reported a position in USNA in Q1 2020 and has held it in 21 quarters since. The position peaked at $17.3K in Q4 2023. 162 funds tracked by Wall St. Rank hold USNA as of Q1 2025.

  • Lindbrook Capital held 34 shares of Usana Health Sciences worth $917 as of Q1 2025.
  • Lindbrook Capital sold 153 Usana Health Sciences shares in Q1 2025, an estimated $4.84K.
  • Usana Health Sciences made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2487 holding.
  • Lindbrook Capital first reported a position in Usana Health Sciences in Q1 2020 and has held it in 21 quarters since.
  • Lindbrook Capital's Usana Health Sciences position peaked at $17.3K in Q4 2023.
  • 162 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.